Back

Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diagnostic accuracy of natriuretic peptides Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yu Takigami

Kitasato University School of Medicine, Sagamihara (Japan)

8 More presentations in this session

Presentation thumbnail
ESC Heart Failure Association age-adjusted natriuretic peptide thresholds for a new diagnosis of heart failure: diagnostic accuracy study
Professor C. Taylor (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Screening for stage B heart failure in Type 2 diabetes: natriuretic peptide screening alone misses echocardiographic abnormalities
Doctor C. Chandramouli (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy
Doctor P. Gouda (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Exploring heart failure prevalence and overlooked dimensions: a comprehensive NT Pro-BNP study in high-risk primary care patients
Professor A. Celik (Mersin, TR)
Abstract Slides Video
Presentation thumbnail
Association of preoperative NT-proBNP with 30-day and five-year mortality after cardiac surgery
Doctor F. Theurl (Innsbruck, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic accuracy of natriuretic peptides

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research
thumbnail
Congress Presentation
Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure
thumbnail
Congress Presentation
Subgroup-specific target of nt-probnp level in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources